Mei Ri Jing Ji Xin Wen·2025-08-15 02:33Core Insights - The Hong Kong internet healthcare stocks experienced a significant rally, with JD Health rising over 13%, Ping An Good Doctor nearly 10%, and Alibaba Health close to 7% [1] - JD Health reported a mid-term revenue of RMB 35.29 billion for the six months ending June 30, 2025, representing a year-on-year increase of 24.5%, and a non-IFRS profit of RMB 3.57 billion, up 35% year-on-year [1] - The strong performance of JD Health has boosted market confidence and injected vitality into the AI healthcare sector, which is characterized by a comprehensive service loop covering medical, testing, diagnosis, and pharmacy [1] - The Chinese government has reinforced its support for AI applications in healthcare, with a focus on AI pathology diagnosis, AI imaging, and AI pharmaceuticals, which are expected to accelerate commercialization [1] Company and Industry Summary - JD Health has established itself as a leader in AI healthcare and internet pharmacy, continuously upgrading and launching full-scenario AI medical products to meet diverse patient and doctor needs [1] - The Hong Kong Stock Connect Medical ETF (520510), which includes major players like JD Health, Ping An Good Doctor, and Alibaba Health, has become a convenient tool for investors looking to capitalize on this high-potential sector [2] - The ongoing exploration of AI applications in healthcare is expected to provide continuous growth momentum for pharmaceutical innovation [1]